Effect of Omega 3 on Periodontitis in Postmenopausal Women
Effect of Omega 3 Fatty Acids on Chronic Periodontitis Patients in Postmenopausal Women: A Randomized Controlled Clinical Study
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
The study was aimed to investigating changes in periodontal parameters and superoxide dismutase activity after root surface debridement with and without Omega 3 fatty acids (ω-3 FAs) supplementation in postmenopausal women. Adjunctive Omega 3 fatty acids supplements reduce periodontal inflammation and improve the status of systemic enzymatic antioxidants in postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jul 2014
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 3, 2016
CompletedFirst Posted
Study publicly available on registry
May 6, 2016
CompletedMay 6, 2016
May 1, 2016
6 months
May 3, 2016
May 5, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
superoxide dismutase (SOD) activity in the gingival crevicular fluid
Superoxide dismutase activity in the gingival crevicular fluid was carried out at baseline, 3 and 6 months post treatment.
up to 6 months
Secondary Outcomes (4)
Plaque Index
up to 6 months
Gingival index
up to 6 months
Probing pocket depth
up to 6 months
Clinical attachment level
up to 6 months
Study Arms (2)
omega 3 group
EXPERIMENTALscaling and root planing omega3 received 2 times daily-for 6 months
control group
PLACEBO COMPARATORscaling and root planing placebo soft gelatin capsules 2 times daily-for 6 months
Interventions
omega3 received 2 times daily-for 6 months
placebo soft gelatin capsules received 2 times daily-for 6 months
Eligibility Criteria
You may qualify if:
- Postmenopausal women with generalized chronic periodontitis (clinical attachment loss more than 30% of the teeth)
- With probing pocket depth ≥ 5mm.
- The age ranged between 45 and 60 years (To avoid the wide variation between individual cases in order to make the sample more homogeneous. Furthermore elderly patients above 60 years are usually not willing to have periodontal treatment).
- Postmenopausal status for at least 1 year.
- Presence of at least six teeth in the mouth.
You may not qualify if:
- Any systemic disease that affect the periodontium.
- Women who take anti-inflammatory drugs, antibiotics or vitamins within the previous 3 month.
- Women who use mouth washes regularly
- Smoking
- History of alcohol abuse
- Participation in other clinical trials.
- Obese women (Body mass index (BMI) ≥ 30).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Enas A Elgendy, MD
October University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass. Prof.
Study Record Dates
First Submitted
May 3, 2016
First Posted
May 6, 2016
Study Start
July 1, 2014
Primary Completion
January 1, 2015
Study Completion
June 1, 2015
Last Updated
May 6, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share